See more : Sibanye Stillwater Limited (SBSW) Income Statement Analysis – Financial Results
Complete financial analysis of Swedencare AB (publ) (SECARE.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Swedencare AB (publ), a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- PT Tanah Laut Tbk (INDX.JK) Income Statement Analysis – Financial Results
- Gold Line International Finvest Limited (GOLDLINE.BO) Income Statement Analysis – Financial Results
- Madhya Bharat Agro Products Limited (MBAPL.NS) Income Statement Analysis – Financial Results
- Huatai Securities Co., Ltd. (601688.SS) Income Statement Analysis – Financial Results
- Public Joint Stock Company “SFI” (SFIN.ME) Income Statement Analysis – Financial Results
Swedencare AB (publ) (SECARE.ST)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.swedencare.se
About Swedencare AB (publ)
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells pet healthcare products. It offers ProDen PlaqueOff powder, a food supplement for cats and dogs, which reduce the formation of plaque and tartar; ProDen PlaqueOff dental bites, a pet dental product; ProDen PlaqueOff powder cat; ProDen PlaqueOff dental bones for dogs; ProDen PlaqueOff mini dental care bones, a chewy bone for smaller dogs; and ProDen PlaqueOff soft chews for dogs and cats. The company also provides dietary supplements for cats, dogs, and horses under the NutriScience brand, such as Glucosamine and Stomax used to renew joint cartilage, bones, muscles, ligaments, and sinews; ArthriAid for joints and mobility; KalmAid, which helps to calm nervous dogs; and OmegaAid and RevitalAid, a feed supplement used for healthy skin and coat. In addition, it develops and manufactures equine supplements, including Gastrocare used to relieve gastric pain and improve appetite; Equine Gold, which helps horse to thrive; ArthriAid used to aid horse's own natural manufacture of cartilage; and AnxiKalm, a supplement to calm excitable horses. Further, the company provides ProDen PlaqueOff teeth and gums, a natural food supplement to enhance dental hygiene and prevent tartar buildup for human. It distributes its products through pharmacies, veterinary clinics, pet shops, animal hospital, and online. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.34B | 1.83B | 770.44M | 239.95M | 126.87M | 99.14M | 85.66M | 54.16M | 46.09M | 24.17M | 18.27M |
Cost of Revenue | 1.05B | 813.88M | 384.57M | 82.60M | 33.82M | 25.62M | 21.91M | 11.65M | 9.07M | 9.22M | 7.58M |
Gross Profit | 1.29B | 1.02B | 385.87M | 157.34M | 93.05M | 73.52M | 63.75M | 42.51M | 37.03M | 14.94M | 10.69M |
Gross Profit Ratio | 55.20% | 55.51% | 50.08% | 65.57% | 73.34% | 74.16% | 74.42% | 78.50% | 80.32% | 61.83% | 58.49% |
Research & Development | 14.60M | 12.75M | 9.44M | 3.91M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 149.85M | 43.62M | 25.19M | 20.54M | 18.48M | 14.58M | 12.95M | 6.24M | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 625.67M | 149.85M | 43.62M | 25.19M | 20.54M | 18.48M | 14.58M | 12.95M | 6.24M | 8.87M |
Other Expenses | 1.10B | 895.49M | 174.12M | 53.70M | 31.48M | 23.47M | 28.57M | 16.60M | 11.88M | 4.14M | 0.00 |
Operating Expenses | 1.12B | 895.49M | 323.97M | 97.32M | 56.67M | 44.01M | 47.04M | 31.18M | 24.82M | 10.39M | 10.73M |
Cost & Expenses | 2.17B | 1.71B | 708.53M | 179.92M | 90.50M | 69.62M | 68.96M | 42.83M | 33.89M | 19.61M | 18.31M |
Interest Income | 1.80M | 293.00K | 1.36M | 1.70M | 224.00K | 0.00 | 1.00K | 725.93K | 31.00K | 52.00K | 186.30K |
Interest Expense | 93.40M | 40.53M | 7.65M | 1.70M | 224.00K | 338.00K | 496.00K | 218.19K | 66.00K | 5.00K | 0.00 |
Depreciation & Amortization | 309.70M | 269.14M | 72.82M | 13.46M | 3.15M | 1.04M | 880.00K | 2.41M | 1.60M | 5.00K | 4.68K |
EBITDA | 484.00M | 392.40M | 138.73M | 54.87M | 40.07M | 30.55M | 22.78M | 14.14M | 8.73M | 6.20M | -1.50M |
EBITDA Ratio | 20.70% | 21.45% | 17.86% | 27.18% | 31.58% | 30.82% | 26.59% | 26.78% | 30.02% | 19.08% | -8.19% |
Operating Income | 173.20M | 119.97M | 64.56M | 60.37M | 36.91M | 29.43M | 16.71M | 11.33M | 12.21M | 6.20M | -1.50M |
Operating Income Ratio | 7.41% | 6.56% | 8.38% | 25.16% | 29.10% | 29.68% | 19.50% | 20.91% | 26.48% | 25.64% | -8.22% |
Total Other Income/Expenses | -92.10M | -39.90M | -7.65M | -1.70M | -224.00K | -339.00K | -495.00K | 148.00K | -9.30K | -1.60M | 1.65M |
Income Before Tax | 81.10M | 80.09M | 56.90M | 58.67M | 36.69M | 29.09M | 16.21M | 11.87M | 12.17M | 4.60M | 145.58K |
Income Before Tax Ratio | 3.47% | 4.38% | 7.39% | 24.45% | 28.92% | 29.34% | 18.92% | 21.92% | 26.40% | 19.04% | 0.80% |
Income Tax Expense | 22.50M | -14.36M | 2.28M | 10.14M | 6.78M | 5.77M | 4.39M | 2.09M | 2.86M | 1.08M | 45.45K |
Net Income | 58.60M | 94.50M | 54.62M | 48.53M | 29.91M | 23.32M | 11.82M | 9.78M | 9.30M | 3.52M | 100.14K |
Net Income Ratio | 2.51% | 5.17% | 7.09% | 20.23% | 23.58% | 23.52% | 13.80% | 18.06% | 20.18% | 14.55% | 0.55% |
EPS | 0.37 | 0.61 | 0.49 | 0.56 | 0.38 | 0.30 | 0.22 | 0.14 | 0.12 | 0.05 | 0.00 |
EPS Diluted | 0.37 | 0.61 | 0.49 | 0.56 | 0.38 | 0.30 | 0.22 | 0.14 | 0.09 | 0.05 | 0.00 |
Weighted Avg Shares Out | 158.73M | 155.35M | 111.95M | 86.79M | 78.89M | 78.85M | 78.85M | 70.27M | 54.88M | 76.98M | 76.98M |
Weighted Avg Shares Out (Dil) | 158.73M | 155.35M | 111.95M | 86.79M | 78.89M | 78.85M | 78.85M | 70.27M | 76.98M | 76.98M | 76.98M |
Source: https://incomestatements.info
Category: Stock Reports